![](/img/cover-not-exists.png)
PDB73 - INDIRECT COST-EFFECTIVENESS ANALYSIS OF EMPAGLIFLOZIN COMPARED TO CANAGLIFLOZIN FOR PATIENTS WITH T2DM AND CARDIOVASCULAR DISEASE IN THE SPANISH NATIONAL HEALTH SERVICE
Carrasco Perez, M., Male, N., Serra Burriel, M., Pfarr, E., Kansal, A.Volume:
21
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.778
Date:
October, 2018
File:
PDF, 378 KB
2018